ruxolitinib
incyte,novartis
['ruxolitinib', 'rux,(-crux),(-trux)', 'vitiligo']
new research presented at the 2022 demonstrates the efficacy of ruxolitinib for nonsegmental #vitiligo: 
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.